Webcasts

Future Webcasts

  • More webcasts coming soon

Previous Webcasts

Thursday, 19 May, 2011

Pharma and Life Sciences Tax Webcast

Please register for a complimentary PricewaterhouseCoopers' Pharmaceutical and Life Sciences Tax Technical Hot Topics webcast on Thursday 19 May, 2011 from 12:00 PM - 1:30 PM (US EST). The webcast will be hosted by Michael Swanick, Global Pharmaceutical and Life Sciences Tax Leader and will cover the following topics:

  • Selected issues facing Pharmaceutical and Life Science companies in creating, developing and exploiting intellectual property within the United States and abroad

    Today, companies face uncertainty and challenges in developing their intellectual property strategy. Pharmaceutical and Life Science companies create vast quantities of high-value intellectual property. As this intellectual property is created and exploited there are a multitude of issues to consider. This area has proven to be a point of contention between taxpayers and the IRS. Issues to be discussed will include the heightened focus on transfer pricing and intellectual property migration by U.S. regulatory authorities, U.S. legislative bodies, the Obama Administration, and the OECD.

  • Legislative landscape facing Pharmaceutical and Life Science companies.

    As corporate tax reform is discussed in Washington, DC, companies need to understand the implications such reform proposals would have on their business. Issues to be discussed will include the various tax reform proposals, potential business and tax reporting impacts for companies and various revenue raising provisions.

  • Other Industry Issues

    Much of the recent tax legislation has significantly impacted the Pharmaceutical & Life Science Industry, mostly notably the Patient Protection and Affordable Care Act. This discussion will briefly highlight other issues affecting Pharmaceutical and Life Science companies including the medical device excise tax, annual fee on branded prescription pharmaceuticals and Puerto Rico excise tax.

     

Who should participate?

Tax VPs/Directors and their tax teams, CFOs, controllers, COOs, finance directors, and senior supply chain executives in pharmaceutical, medical device and biotechnology companies.
Recommended CPE: application of 1.5 CPE taxation credit is in place.

Webcast Registration and Login
To enter the webcast, please log on to the following URL 15 minutes prior to the scheduled start time.

http://event.on24.com/r.htm?e=302203&s=1&k=99E6C381094E84318D8C2B9C108E179C

NOTE: Please make sure you can access the webcast in advance. If for any reason you cannot open the link/presentation, please contact Marina Bello Valcarce at marina.bello.valcarce@uk.pwc.com or Kathleen Un at kathleen.un@us.pwc.com.

Plain-English Accounting is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be addressed to the National Registry of CPE Sponsors, 150 Fourth Avenue North, Suite 700, Nashville, TN, 37219-2417. Web site: www.nasba.org

26 April, 2011

Pharma 2020: Supplying the future

In this Webcast, a panel of specialists will discuss significant changes the pharmaceutical supply chain is expected to undergo in the coming years and then explore potential scenarios for how pharmaceutical companies might restructure their supply chain strategy and operating models, depending on their unique product portfolio and channel strategy. The discussion will focus on the risks, opportunities and challenges in each of the four future supply chain models -- virtual manufacturer, service innovator, a mass market manufacturer or a profit center – identified by PwC in its groundbreaking report Pharma 2020: Supplying the Future: Which path will you take?

25 January, 2011

Medical Technology Innovation Scorecard: The race for global leadership

The presentation focuses on the PwC, Medical Technology Innovation Scorecard: The race for global leadership, released on Tuesday 18 January, 2011, which evaluates the innovative capacity and capabilities of nine countries, all current or emerging leaders in medical technology in order track global shifts in medical device innovation.

http://event.on24.com/eventRegistration/prereg/register.jsp?eventid=279488&sessionid=1&key=F45893C1641A6416AEBC2CC606C9C291

16 December, 2010

Pharmaceutical and Life Sciences Tax Technical Hot Topics webcast: New Excise Tax in Puerto Rico - Act 154

Victor Rodriguez, Partner and Alan Fischl, Principal, discusses the enactment of the Puerto Rico new temporary excise tax on offshore manufacturers as amended by Act 154, signed into law October 25 by Governor Luis G. Fortuño.

http://event.on24.com/eventRegistration/prereg/register.jsp?eventid=236160&sessionid=1&key=F750666E94A40B03316397FDE4ADCB53

September 16, 2010

New Excise Taxes on Pharmaceutical and Medical Device Manufacturers and; New Irish Transfer Pricing Regulations for Global Pharmaceutical, Medical Device and Biotechnology Companies

Please register for a complimentary PwC's Pharmaceutical and Life Sciences Tax Technical Hot Topics webcast on Thursday 16 September, 2010 from 12:00 PM - 1:00 PM (US EST). The webcast was hosted by Michael Swanick, Global Pharmaceutical and Life Sciences Tax Leader and will cover the following two topics:

http://event.on24.com/eventRegistration/prereg/register.jsp?eventid=264994&sessionid=1&key=C09E88B87C7CA9E5BA8F0E14C2457874

May 25, 2010

Deciphering the initial Treasury guidance on Section 48D therapeutic discovery project credit,

On this webcast, a panel of PwC Life Science and Pharmaceutical industry specialists, National Tax, Economics and Government Grant specialists, as well as invited government speakers, discussed and assessed anticipated guidance on how companies may qualify and apply for the Section 48D therapeutic discovery project credit (or a grant in lieu of the credit).

The Webcast provided an initial overview of the Treasury guidance, a discussion of the programme's eligibility and selection criteria, and how the credit/grant application process works.

18 March 2010

Leveraging tax for your supply chain - planning considerations for global pharmaceutical, medical device and biotechnology companies

http://event.on24.com/r.htm?e=193559&s=1&k=F96A33DBA631AD96A41AA345F10924DF

17 December 2009

Pharma 2020: Taxing times ahead - Which path will you take?

http://event.on24.com/r.htm?e=182329&s=1&k=7881E76C34773AB8F623DF5588497327

15 October, 2009

US healthcare reform: A briefing on the major business and tax impacts affecting pharmaceutical, medical device and biotechnology companies

Webcasts - Previous webcasts go

8 July, 2009

US Tax Reform Proposals and the New Irish Intellectual Property Rules - Impact on Pharma, Life Sciences and Medical Device Companies

7 April, 2009

New Cost Sharing Regulations and implications for the Pharma, Life Sciences and Medical Device Companies

Webcast Registration and Login go
7 May, 2009

Podcast: Update on China's changing pharmaceutical landscape

Michael Keech, director, Pharmaceutical and Life Sciences Advisory Services Group, being interviewed by Genetic Engineering News on the changing pharmaceutical landscape in China.

10 February, 2009

Audioconference: Sales & Marketing Disclosure Requirements

Update on Sales and Marketing Disclosure Requirements for Drug, Device and Biotech Companies

For more information, click herego

27 January, 2009

IFRS conversion: Understanding the key tax issues for Pharmaceuticals, Life Sciences and Medical Devices companies

Key discussion topics include planning considerations and tax accounting method changes.

Archive go

President-Elect Obama's Plans for Healthcare and Tax
19 December, 2008

President-Elect Obama's Plans for Healthcare and Tax

Access the presentation - Adobe Acrobat file (201kb)